Enjaymo 1,100 mg/22 mL (50 mg/mL) injection Images
Generic Name: sutimlimab
This medication has been identified as Enjaymo 1,100 mg/22 mL (50 mg/mL) injection. It is supplied by Bioverativ U.S. LLC.
Enjaymo is used in the treatment of Cold Agglutinin Disease and belongs to the drug class selective immunosuppressants. Enjaymo 1,100 mg/22 mL (50 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Enjaymo
- Generic Name
- sutimlimab
- Strength
- 1,100 mg/22 mL (50 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bioverativ U.S. LLC
- National Drug Code (NDC)
- 80203-0347
See also:
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Afinitor Disperz
Afinitor Disperz is used for subependymal giant cell astrocytoma, tuberous sclerosis complex
Ubrelvy
Ubrelvy (ubrogepant) tablets are used for the acute treatment of migraine. Includes Ubrelvy side ...
Arava
Arava (leflunomide) is used to treat the symptoms of rheumatoid arthritis and help reduce joint ...
Arzerra
Arzerra is used to treat chronic lymphocytic leukemia (CLL), usually in combination with other ...
Aubagio
Aubagio (teriflunomide) is used to reduce flare-ups in people with relapsing multiple sclerosis ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
More about Enjaymo (sutimlimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.